Cardiology 2013. Part II.

Volume: 14

Issue: 1

Pages: 1-2

Date: Jan-Feb

Short Title: Outcome improvement for STEMI patients: the next breakthrough in interventional cardiology?

Alternate Journal: Cardiovascular revascularization medicine : including molecular interventions

ISSN: 1878-0938 (Electronic)

1878-0938 (Linking)

DOI: 10.1016/j.carrev.2012.12.011

Accession Number: 23337377

Keywords: Health Promotion

Health Services Accessibility

Humans

Myocardial Infarction/epidemiology/prevention & control/*therapy

Outcome and Process Assessment (Health Care)

*Percutaneous Coronary Intervention/instrumentation

Primary Prevention

*Quality Improvement

Risk Factors

Risk Reduction Behavior

Stents

*Thrombectomy

Treatment Outcome

Notes: Waksman, Ron

eng

Editorial

Introductory

2013/01/23 06:00

Cardiovasc Revasc Med. 2013 Jan-Feb;14(1):1-2. doi: 10.1016/j.carrev.2012.12.011.

URL: http://www.ncbi.nlm.nih.gov/pubmed/23337377

 

 

Reference Type:  Journal Article

Record Number: 1033Author: West, N. E.

Year: 2013

Title: The Year in Cardiology 2012: acute coronary syndromes

Journal: Eur Heart J

Volume: 34

Issue: 6

Pages: 422-6

Date: Feb

Short Title: The Year in Cardiology 2012: acute coronary syndromes

Alternate Journal: European heart journal

ISSN: 1522-9645 (Electronic)

0195-668X (Linking)

DOI: 10.1093/eurheartj/ehs462

Accession Number: 23284094

Keywords: Acute Coronary Syndrome/mortality/*therapy

Anticoagulants/therapeutic use

Arrhythmias, Cardiac/mortality

Bone Marrow Transplantation/methods

Electrocardiography

Humans

Magnetic Resonance Angiography

Myocardial Infarction/mortality/*therapy

Organ Sparing Treatments/methods

Percutaneous Coronary Intervention/methods

Platelet Aggregation Inhibitors/therapeutic use

Practice Guidelines as Topic

Randomized Controlled Trials as Topic

Risk Assessment

Abstract: Patients presenting with acute coronary syndromes (ACS) remain amongst the highest-risk of all acute medical admissions. Despite significant reductions in morbidity and mortality via refinements in treatment methods in recent years, such individuals remain at a high risk of recurrent ischaemic events and death. Whilst 2012 has brought a wealth of novel data in the field of ACS regarding diagnosis and both medical and invasive management strategies, continued focus on this high-risk patient subset is necessary to further our understanding and improve patient outcomes.

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205